198 related articles for article (PubMed ID: 21196187)
1. Type II transmembrane serine protease (TTSP) deregulation in cancer.
Webb SL; Sanders AJ; Mason MD; Jiang WG
Front Biosci (Landmark Ed); 2011 Jan; 16(2):539-52. PubMed ID: 21196187
[TBL] [Abstract][Full Text] [Related]
2. The type II transmembrane serine protease, matriptase-2: Possible links to cancer?
Sanders AJ; Webb SL; Parr C; Mason MD; Jiang WG
Anticancer Agents Med Chem; 2010 Jan; 10(1):64-9. PubMed ID: 20015002
[TBL] [Abstract][Full Text] [Related]
3. Type II transmembrane serine proteases in development and disease.
Szabo R; Bugge TH
Int J Biochem Cell Biol; 2008; 40(6-7):1297-316. PubMed ID: 18191610
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections.
Ohler A; Becker-Pauly C
Biol Chem; 2012 Sep; 393(9):907-14. PubMed ID: 22944691
[TBL] [Abstract][Full Text] [Related]
5. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer.
Netzel-Arnett S; Hooper JD; Szabo R; Madison EL; Quigley JP; Bugge TH; Antalis TM
Cancer Metastasis Rev; 2003; 22(2-3):237-58. PubMed ID: 12784999
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer.
Kim S
Exp Mol Med; 2023 Apr; 55(4):716-724. PubMed ID: 37009799
[TBL] [Abstract][Full Text] [Related]
7. The role of type II transmembrane serine protease-mediated signaling in cancer.
Tanabe LM; List K
FEBS J; 2017 May; 284(10):1421-1436. PubMed ID: 27870503
[TBL] [Abstract][Full Text] [Related]
8. Neurobin/TMPRSS11c, a novel type II transmembrane serine protease that cleaves fibroblast growth factor-2 in vitro.
Stallmach R; Gloor SM
Biochem J; 2008 May; 412(1):81-91. PubMed ID: 18215125
[TBL] [Abstract][Full Text] [Related]
9. Type II transmembrane serine proteases.
Bugge TH; Antalis TM; Wu Q
J Biol Chem; 2009 Aug; 284(35):23177-81. PubMed ID: 19487698
[TBL] [Abstract][Full Text] [Related]
10. Type II transmembrane serine proteases.
Szabo R; Wu Q; Dickson RB; Netzel-Arnett S; Antalis TM; Bugge TH
Thromb Haemost; 2003 Aug; 90(2):185-93. PubMed ID: 12888865
[TBL] [Abstract][Full Text] [Related]
11. Type II transmembrane serine proteases in cancer and viral infections.
Choi SY; Bertram S; Glowacka I; Park YW; Pöhlmann S
Trends Mol Med; 2009 Jul; 15(7):303-12. PubMed ID: 19581128
[TBL] [Abstract][Full Text] [Related]
12. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis.
Folgueras AR; de Lara FM; Pendás AM; Garabaya C; Rodríguez F; Astudillo A; Bernal T; Cabanillas R; López-Otín C; Velasco G
Blood; 2008 Sep; 112(6):2539-45. PubMed ID: 18523150
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
Hashimoto T; Kato M; Shimomura T; Kitamura N
FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
[TBL] [Abstract][Full Text] [Related]
14. The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.
Murray AS; Hyland TE; Sala-Hamrick KE; Mackinder JR; Martin CE; Tanabe LM; Varela FA; List K
Oncogene; 2020 Oct; 39(41):6421-6436. PubMed ID: 32868877
[TBL] [Abstract][Full Text] [Related]
15. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
Damalanka VC; Janetka JW
Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556
[TBL] [Abstract][Full Text] [Related]
16. Type II transmembrane serine proteases as potential targets for cancer therapy.
Murray AS; Varela FA; List K
Biol Chem; 2016 Sep; 397(9):815-26. PubMed ID: 27078673
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary history of type II transmembrane serine proteases involved in viral priming.
Forni D; Sironi M; Cagliani R
Hum Genet; 2022 Nov; 141(11):1705-1722. PubMed ID: 35122525
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization.
Murray AS; Varela FA; Hyland TE; Schoenbeck AJ; White JM; Tanabe LM; Todi SV; List K
J Biol Chem; 2017 Sep; 292(36):14867-14884. PubMed ID: 28710277
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness.
Guipponi M; Antonarakis SE; Scott HS
Front Biosci; 2008 Jan; 13():1557-67. PubMed ID: 17981648
[TBL] [Abstract][Full Text] [Related]
20. DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.
Zmora P; Blazejewska P; Moldenhauer AS; Welsch K; Nehlmeier I; Wu Q; Schneider H; Pöhlmann S; Bertram S
J Virol; 2014 Oct; 88(20):12087-97. PubMed ID: 25122802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
